menu
    • menu

    Company profile for Innocan Pharma

    NEW Drugs in Dev: 1
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Innocan Pharma is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”) with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. The Company’s operations and research and development activities are based in Israel. Innocan Pharma’s business can be described as three distinct operating segments r...
    Innocan Pharma is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”) with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. The Company’s operations and research and development activities are based in Israel. Innocan Pharma’s business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) the research and development of the treatment of Covid-19 (and other viruses causing lung inflammation as well as other central nervous system

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Innocan PharmaIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Dizengoff St 50, Tel Aviv, Tel Aviv 6433
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://innocanpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innocan Pharma Posts Q1 2026 Revenue Up 29.7% to $6.47M
    Innocan Pharma Posts Q1 2026 Revenue Up 29.7% to $6.47M

    27 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-posts-strong-q1-2026-results-with-revenue-surging-29-7-to-us6-47m-302783539.html

    PR NEWSWIRE
    27 May 2026
    Share Share
    Innocan Pharma Announces Closing Of Additional Debenture
    Innocan Pharma Announces Closing Of Additional Debenture

    06 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-announces-closing-of-additional-debenture-302734620.html

    PR NEWSWIRE
    06 Apr 2026
    Share Share
    Innocan Pharma Announces Additional Debenture to Tamar Innovest
    Innocan Pharma Announces Additional Debenture to Tamar Innovest

    31 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-announces-offering-of-an-additional-debenture-to-tamar-innovest-302730169.html

    PR NEWSWIRE
    31 Mar 2026
    Share Share
    Innocan Reports 2025 Financial Result, with Revenues at US $26.6M
    Innocan Reports 2025 Financial Result, with Revenues at US $26.6M

    31 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-reports-2025-financial-results-with-revenues-at-us-26-6m-302729643.html

    PR NEWSWIRE
    31 Mar 2026
    Share Share
    Innocan Pharma Finalizes Debenture Deal With Top Shareholder
    Innocan Pharma Finalizes Debenture Deal With Top Shareholder

    16 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-announces-closing-of-a-debenture-to-its-largest-shareholder-tamar-innovest-302715189.html

    PR NEWSWIRE
    16 Mar 2026
    Share Share
    Innocan Pharma Offers Debenture To Top Shareholder Tamar Innovest
    Innocan Pharma Offers Debenture To Top Shareholder Tamar Innovest

    12 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-announces-offering-of-a-debenture-to-its-largest-shareholder-tamar-innovest-302711582.html

    PR NEWSWIRE
    12 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search